APA (7th ed.) Citation

Engelman, J. A., Zejnullahu, K., Mitsudomi, T., Song, Y., Hyland, C., Park, J. O., . . . Jänne, P. A. (2007). MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling. Science (pre-March 2025), 316(5827), 1039. https://doi.org/10.1126/science.1141478

Chicago Style (17th ed.) Citation

Engelman, Jeffrey A., et al. "MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling." Science (pre-March 2025) 316, no. 5827 (2007): 1039. https://doi.org/10.1126/science.1141478.

MLA (9th ed.) Citation

Engelman, Jeffrey A., et al. "MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling." Science (pre-March 2025), vol. 316, no. 5827, 2007, p. 1039, https://doi.org/10.1126/science.1141478.